Abstract
The antigen specificity of T lymphocytes is dictated solely by the T cell receptor (TCR) α and β chains. Consequently, genetic transfer of TCR chains may be an appealing strategy with which to impose a desirable virus- or tumor-antigen specificity onto cytotoxic or helper T cell populations. We describe here the genetic introduction of a virus-specific TCR into peripheral T cells in a mouse model system. These experiments showed that T cells redirected by TCR gene transfer expanded upon viral infection of mice and efficiently homed to effector sites. In this setting, TCR gene transfer was not associated with any significant autoimmune pathology. In addition, small numbers of TCR-transduced T cells promoted the rejection of antigen-expressing tumors in vivo. These data suggest that the redirection of T cells by TCR gene transfer is a viable strategy for the rapid induction of virus- or tumor-specific immunity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mueller, N. Overview of the epidemiology of malignancy in immune deficiency. J. Acquir. Immune Defic. Syndr. 21, S5–10 (1999).
Shankaran, V. et al. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410, 1107–1111 (2001).
Kolb, H. J. et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood 86, 2041–2050 (1995).
Collins, R. H. Jr et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J. Clin. Oncol. 15, 433–444 (1997).
Heslop, H. E. & Rooney, C. M. Adoptive cellular immunotherapy for EBV lymphoproliferative disease. Immunol. Rev. 157, 217–222 (1997).
Goulmy, E. et al. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N. Engl. J. Med. 334, 281–285 (1996).
Dembic, Z. et al. Transfer of specificity by murine α and β T-cell receptor genes. Nature 320, 232–238 (1986).
Clay, T. M. et al. Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity. J. Immunol. 163, 507–513 (1999).
Cooper, L. J., Kalos, M., Lewinsohn, D. A., Riddell, S. R. & Greenberg, P. D. Transfer of specificity for human immunodeficiency virus type 1 into primary human T lymphocytes by introduction of T-cell receptor genes. J. Virol. 74, 8207–8212 (2000).
Fujio, K. et al. Functional reconstitution of class II MHC-restricted T cell immunity mediated by retroviral transfer of the α β TCR complex. J. Immunol. 165, 528–532 (2000).
Townsend, A. R., Gotch, F. M. & Davey, J. Cytotoxic T cells recognize fragments of the influenza nucleoprotein. Cell 42, 457–467 (1985).
Kitamura, T. New experimental approaches in retrovirus-mediated expression screening. Int. J. Hematol. 67, 351–359 (1998).
Flynn, K. J. et al. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity 8, 683–691 (1998).
Haanen, J. B. et al. Systemic T cell expansion during localized viral infection. Eur. J. Immunol. 29, 1168–1174 (1999).
Belz, G. T., Altman, J. D. & Doherty, P. C. Characteristics of virus-specific CD8(+) T cells in the liver during the control and resolution phases of influenza pneumonia. Proc. Natl Acad. Sci. USA 95, 13812–13817 (1998).
Whitmire, J. K. & Ahmed, R. Costimulation in antiviral immunity: differential requirements for CD4(+) and CD8(+) T cell responses. Curr. Opin. Immunol. 12, 448–455 (2000).
Sandberg, J. K. et al. Superdominance among immunodominant H-2Kb-restricted epitopes and reversal by dendritic cell-mediated antigen delivery. J. Immunol. 160, 3163–3169 (1998).
Murphy, W. J. & Blazar, B. R. New strategies for preventing graft-versus-host disease. Curr. Opin. Immunol. 11, 509–515 (1999).
Heikkinen, T. & Chonmaitree, T. Increasing importance of viruses in acute otitis media. Ann. Med. 32, 157–163 (2000).
Glezen, W. P. Prevention of acute otitis media by prophylaxis and treatment of influenza virus infections. Vaccine 19, S56–58 (2000).
Busch, D. H. & Pamer, E. G. T cell affinity maturation by selective expansion during infection. J. Exp. Med. 189, 701–710 (1999).
Jahner, D. et al. De novo methylation and expression of retroviral genomes during mouse embryogenesis. Nature 298, 623–628 (1982).
Challita, P. M. & Kohn, D. B. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc. Natl Acad. Sci. USA 91, 2567–2571 (1994).
Robbins, P. B. et al. Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells. Proc. Natl Acad. Sci. USA 95, 10182–10187 (1998).
May, C. et al. Therapeutic haemoglobin synthesis in β-thalassaemic mice expressing lentivirus-encoded human β-globin. Nature 406, 82–86 (2000).
Hekele, A. et al. Growth retardation of tumors by adoptive transfer of cytotoxic T lymphocytes reprogrammed by CD44v6-specific scFv:η-chimera. Int. J. Cancer 68, 232–238 (1996).
Altenschmidt, U., Klundt, E. & Groner, B. Adoptive transfer of in vitro -targeted, activated T lymphocytes results in total tumor regression. J. Immunol. 159, 5509–5515 (1997).
Willemsen, R. A. et al. Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR. Gene Ther. 7, 1369–1377 (2000).
Viola, A. & Lanzavecchia, A. T cell activation determined by T cell receptor number and tunable thresholds. Science 273, 104–106 (1996).
Kalergis, A. M. et al. Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex. Nature Immunol. 2, 229–234 (2001).
Backstrom, B. T. et al. A motif within the T cell receptor α chain constant region connecting peptide domain controls antigen responsiveness. Immunity 5, 437–447 (1996).
Ulivieri, C., Peter, A., Orsini, E., Palmer, E. & Baldari, C. T. Defective Signaling to Fyn by a T Cell Antigen Receptor Lacking the α-Chain Connecting Peptide Motif. J. Biol. Chem. 276, 3574–3580 (2001).
Holler, P. D. et al. In vitro evolution of a T cell receptor with high affinity for peptide/MHC. Proc. Natl Acad. Sci. USA 97, 5387–5392 (2000).
Kessels, H. W., van den Boom, M. D., Spits, H., Hooijberg, E. & Schumacher, T. N. Changing T cell specificity by retroviral T cell receptor display. Proc. Natl Acad. Sci. USA 97, 14578–14583 (2000).
Stanislawski, T. et al. Circumventing tolerance to a human mdm2 derived tumor antigen by TCR gene transfer. Nature Immunol. 2, 962–970 (2001).
Atwell, S., Ridgway, J. B., Wells, J. A. & Carter, P. Stable heterodimers from remodeling the domain interface of a homodimer using a phage display library. J. Mol. Biol. 270, 26–35 (1997).
Muller, A. et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50–56 (2001).
Altman, J. D. et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94–96 (1996).
Gorer, P. A. Studies in antibody response of mice to tumour inoculation. Br. J. Cancer 4, 372–379 (1950).
Harrison, P. T. An ethanol-acetic acid-formol saline fixative for routine use with special application to the fixation of non-perfused rat lung. Lab. Anim. 18, 325–331 (1984)
Acknowledgements
We thank M. Toebes for preparation of the MHC tetramers; C. de Goeij, C. Boersema, J. Bulthuis and M. Tjin-A-Koeng for histotechnical assistance; G. Rimmelzwaan for growing and titrating the various influenza strains; T. Kitamura for the pMX retroviral vector; G. Nolan for the Phoenix-E cell line; and E. Noteboom and A. Pfauth for assistance with flow cytometry analysis. Supported by the Dutch Cancer Society (NKI 97-1442 and NKI 99-2036) and the Netherlands Organization for Scientific Research (NWO pioneer grant 00-03).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kessels, H., Wolkers, M., van den Boom, M. et al. Immunotherapy through TCR gene transfer. Nat Immunol 2, 957–961 (2001). https://doi.org/10.1038/ni1001-957
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni1001-957
This article is cited by
-
Translational repression of pre-formed cytokine-encoding mRNA prevents chronic activation of memory T cells
Nature Immunology (2018)
-
T-cell receptor-engineered T cells for cancer treatment: current status and future directions
Protein & Cell (2018)
-
Systematic comparison of 2A peptides for cloning multi-genes in a polycistronic vector
Scientific Reports (2017)
-
Development of genetically engineered iNKT cells expressing TCRs specific for the M. tuberculosis 38-kDa antigen
Journal of Translational Medicine (2015)
-
Orchestrating an immune response against cancer with engineered immune cells expressing αβTCRs, CARs, and innate immune receptors: an immunological and regulatory challenge
Cancer Immunology, Immunotherapy (2015)